Form 4: Biohaven CEO Vlad Coric Acquires Shares in Public Offering

Biohaven CEO Vlad Coric reports the acquisition of 21,052 common shares at $47.50 each through an underwritten public offering.

Summary

• On October 2, 2024, Vlad Coric, CEO of Biohaven Ltd., acquired 21,052 common shares of Biohaven at a price of $47.50 per share.
• The shares were acquired through an underwritten public offering.
• Following the transaction, Coric directly owns 1,789,159 common shares.
• Coric also has indirect ownership through The Vlad Coric Family Trust (861,942 shares), The Vladimir Coric Marital Trust (407,213 shares), and a 401(K) Plan (109,565 shares).
• The Vlad Coric Family Trust is managed by Coric's spouse, and Coric disclaims beneficial ownership of the shares held by the trust.
• The reported balance includes 742 shares acquired through the Biohaven Employee Share Purchase Plan on May 31, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The CEO's purchase could be seen as positive, but it's a routine transaction disclosure.

Positives

• The CEO's purchase of shares in a public offering could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The CEO's share purchase could positively influence shareholder sentiment.

Key Dates